PS15(PM) Persistent pelvic pain and endometriosis 2024 PILOT
This document advocates for a shift in the approach to managing persistent pelvic pain (PPP), moving away from a sole focus on endometriosis as the primary cause. It emphasizes a comprehensive, whole-person approach that addresses the complex interplay of psychological, social...
ANZCA statement on PPE
ANZCA statement on personal protection equipment (PPE) during the SARS-CoV-2
pandemic
ANZCA COVID-19 PPE Statement
Archived- ANZCA COVID-19 PPE Statement
PG52 Guideline for transport of critically ill patients 2024 (PILOT)
The aim of this document is to assist clinicians, health services and organisations develop and implement strategies and protocols for the transport of critically ill patients in order to minimise risks and maximise safety for patients and accompanying staff during transport.
11-Final-ANZCA-response-to-CAA-20180523-(002)
ANZCA Gender Pay Gap Employer Statement
Under the Workplace Gender Equality Amendment (Closing the Gender Pay Gap) 2023 and associated legislative instruments, organisations with more than 100 employees arerequired to have their gender pay gap published by the Workplace Gender Equality Agency (WGEA) along with an In...
PS02(A) Position statement on credentialling and defining scope of clinical practice in anaesthesia
Position statement on credentialling and defining the scope of clinical practice in anaesthesia
PS12(PM) Position statement on the use of ketamine in the management of chronic non-cancer pain
Statement from the Faculty of Pain Medicine on the use of ketamine with reference to its use in the management of patients with chronic non-cancer pain.
PS55BP Position statement on minimum facilities for safe administration of anaesthesia BP
This background outlines the justification in the ANZCA statement on the minimum requirements for healthcare facilities to ensure safe anaesthesia administration.